Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

About Diabetes » Cure

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Nanoparticle Vaccine Used to Cure Type 1 Diabetes
Posted: Sunday, April 18, 2010
Using a sophisticated nanotechnology-based "vaccine," researchers were able to successfully cure mice with Type 1 diabetes and slow the onset of the disease in mice at risk for the disease.

Study Explains How Weight-loss Surgery Reverses Type 2 Diabetes
Posted: Sunday, April 04, 2010
A team of researchers, led by a University of California Davis (UC Davis) veterinary endocrinologist, has shown for the first time that a surgical procedure in rats that is similar to bariatric surgery in humans...

Key to Reversing Type 1 Diabetes Discovered
Posted: Sunday, February 14, 2010
Doctors at Eastern Virginia Medical School's Strelitz Diabetes Center have been stalking the culprit responsible for Type 1 diabetes. Now, they are one step closer.

Andrew P. Mandell - Mr. Diabetes® to Sit On ProtoKinetix Advisory Board
Posted: Friday, January 15, 2010
Andrew P. Mandell - Mr. Diabetes®, Executive Director of Defeat Diabetes Foundation and diabetes advocate announced today that he will be sitting on the ProtoKinetix (PKTX) Advisory Board. ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycoproteins (AAGP™) for medicine and the biotechnology and cosmetic industries.

ProtoKinetix’ AAGP™ Shows Promise as a Tool in Diabetes Treatment / Cure
Posted: Tuesday, January 12, 2010
Independent studies done by universities and corporations have illustrated a remarkable increase in the yield of viable stem cells after cryopreservation using AAGP™ in the freeze-thaw process. One future approach to increasing diabetics’ insulin production is related to an ability to convert their stem cells into islet cells for transplantation. The feasibility of this procedure is dependent upon the amount of functioning islet cells that can be derived from the patient’s stem cells. This is where AAGP™ can make a very beneficial contribution.

Regaining Normal Glucose Function in Patients with Prediabetes
Posted: Sunday, January 03, 2010
Diabetes prevention likely resides in the restoration of Normal Glucose Regulation (NGR) rather than in the maintenance of a high-risk state, such as pre-diabetes. Therefore, it is encouraging to note that nearly one quarter of the study participants achieved NGR within the 3-year study window. Over half of those patients did so in the first year, so for the most part, those who succeed in having NGR restored will do so relatively quickly.

Discovery of Insulin Production Mechanism Can Lead to Better Treatment for Diabetes
Posted: Monday, November 23, 2009
How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem.

Newer, More Effective Laser Treatment for Diabetic Macular Edema
Posted: Monday, November 09, 2009
A sub-threshold micropulse diode laser (MPDL) is as effective as a conventional green laser (CGL) for the photocoagulation of diabetes-related macular edema, according to the results of a controlled trial.

New Key to Understanding Type 1 Diabetes
Posted: Wednesday, October 14, 2009
St. Jude Children's Research Hospital investigators have discovered how destructive immune cells gain access to insulin-producing cells and help cause diabetes. The finding points to possible new strategies to halt or prevent Type 1 diabetes.

Update on Dr. Faustman's Research on Reversing Type 1 Diabetes
Posted: Wednesday, September 23, 2009
The Faustman Lab at Massachusetts General Hospital, run by Denise L. Faustman, MD, PhD, is moving rapidly through the clinical trial challenge to test and possibly establish a vaccine using a generic drug, Bacillus Calmette-Guérin (BCG) to reverse Type 1 diabetes.

Page 4 of 12
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  >   >>   >| 

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement